DON SELLERS

Mr. Sellers is a pharmaceutical and biotechnology executive with over 40 years of management experience including extensive international success. He currently is the Chief Executive Officer and Chairman of CardioPharma, Inc., a cardiovascular start-up, board member of Certus, an oncology start-up, and a member of Life Science Angels, a San Francisco Bay Area angel investing group. From 1993 to 2004, Mr. Sellers served as President, Chief Executive Officer and a Director of SciClone Pharmaceuticals. While at SciClone, he also established a profitable international subsidiary and created the clinical and marketing programs that resulted in the highly successful marketing of China’s leading imported finished pharmaceutical product, Zadaxin. Prior to SciClone, Mr. Sellers’ global pharmaceutical industry experience included work with Pfizer, the Revlon Healthcare Group, a regional Presidency with Sterling Drug International, Presidency with Muller & Phipps Japan, and the Pritzker organization, where he served as a Corporate Vice President focused on pharmaceuticals and biomed devices.

Mr. Sellers received an A.B. degree from Lafayette College and a Master of International Management degree with honors from the Thunderbird Graduate School of International Management.